Comparison of IgE measurements using the pharmacia CAP systems in European community respiratory health surveys I and II
J. Potts, C. Luczynska, S. Chinn, D. Jarvis, P. Burney (London, United Kingdom)
Source: Annual Congress 2002 - Epidemiology of asthma, rhinitis and allergy
Session: Epidemiology of asthma, rhinitis and allergy
Session type: Thematic Poster Session
Number: 808
Disease area: Airway diseases
Abstract The European Community Respiratory Health Survey II (ECRHS II) is a multi-centre study investigating changes in the prevalence of asthma symptoms and risk factors for asthma, and is a follow-up study to ECRHS I conducted ten years ago. Key to these investigations is the measurement of atopy and the need to measure serum IgE levels using comparable methodology in both studies as, necessarily, ECRHS II is using a different and updated CAP System and different reagents to ECRHS I. To compare IgE measurements we re-assayed 636 serum samples from Ipswich and Norwich collected for ECRHS I. The table shows the ratio between geometric mean (GM) IgE measured in 1992 and 2001. As the values have increased, we compared the correlation within subjects to test whether this was due to evaporation of samples in the freezer. Results suggest that differences in equipment and/or allergen CAPs is the more likely explanation. To test the inherent variation in the assay we compared 174 duplicate IgE results from Ipswich and Norwich ECRHS II sera and found good agreement. This analysis indicates that serum IgE measurements are sufficiently reliable to allow comparisons of changes in the prevalence of atopy between centres and by risk factors in the ECRHS.
GM in 1992 GM in 2001 Ratio (95% confidence interval) Total IgE 34.30 49.76 1.45 (1.36-1.55) D. pteronyssinus (d1)0.72 0.81 1.12 (1.07-1.17) Cat (e1) 0.48 0.50 1.05 (1.01-1.09) Timothy grass (g6) 0.72 0.79 1.10 (1.05-1.14) Cladosporium herbarum (m2)0.38 0.38 1.00 (0.98-1.02)
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Potts, C. Luczynska, S. Chinn, D. Jarvis, P. Burney (London, United Kingdom). Comparison of IgE measurements using the pharmacia CAP systems in European community respiratory health surveys I and II. Eur Respir J 2002; 20: Suppl. 38, 808
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
The socio-economic cost of persistent asthma in the European community respiratory health survey (ECRHS) II Source: Annual Congress 2009 - Epidemiology of atopy and asthma Year: 2009
PM2.5 assessment at 21 study centres of ECRHS II (European community respiratory health survey II) Source: Eur Respir J 2002; 20: Suppl. 38, 131s Year: 2002
Asthma control and its determinants. The European community respiratory health survey (ECRHS) II Source: Eur Respir J 2007; 30: Suppl. 51, 632s Year: 2007
Dietary patterns and asthma: results from three countries in the European community respiratory health survey (ECRHS) Source: Annual Congress 2008 - Epidemiology of asthma and allergy Year: 2008
Sensitization to common allergens and pulmonary function in the European community respiratory health survey (ECRHS) Source: Eur Respir J 2001; 18: Suppl. 33, 351s Year: 2001
Risk factors for new-onset cat sensitisation in the European community respiratory health survey (ECRHS) II Source: Annual Congress 2009 - Epidemiology of atopy and asthma Year: 2009
Gene-environment interactions in occupational asthma in the European community respiratory health survey (ECRHS) Source: Annual Congress 2009 - Environmental factors, susceptibility, asthma and COPD Year: 2009
Oxidative properties of PM2.5 in the European community respiratory health survey cities (ECRHS) Source: Eur Respir J 2004; 24: Suppl. 48, 605s Year: 2004
What defines abnormal lung function in asthma? Results from European community respiratory health survey (ECRHS) Source: Annual Congress 2008 - Severe asthma: a heterogeneous clinical entity Year: 2008
Respiratory-related sick leave-European community respiratory health survey II (ECRHS II) Source: Annual Congress 2009 - High molecular sensitisers and biological dusts Year: 2009
Influence of socioeconomic status on asthma symptoms and atopy: results form the European community respiratory health survey (ECRHS) Source: Eur Respir J 2002; 20: Suppl. 38, 8s Year: 2002
Is asthma treatment compliance improved over the last ten years? The results of the European community respiratory health survey (ECRHS)-II Source: Annual Congress 2004 - Asthma and allergy overtime: risks and management Year: 2004
Respiratory-related work disability in the European community respiratory health survey Source: Eur Respir J 2002; 20: Suppl. 38, 323s Year: 2002
Outcomes of latex-induced respiratory disorders in health care workers (HCW) after 5 year of clinical survey Source: Eur Respir J 2006; 28: Suppl. 50, 699s Year: 2006
Management of community acquired pneumonia in UK hospitals: a survey of the availability of local guidelines and severity assessment tools Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007
Correlations between PM2.5 mass, sulphur and lead content, reflection, and NO2 , across 21 study centres of ECRHS II (European community respiratory health survey II) Source: Eur Respir J 2003; 22: Suppl. 45, 556s Year: 2003
Respiratory intermediate care units: a European survey Source: Guideline 2002 Year: 2002
Change in prevalence of IgE sensitization over 20 years in the European community respiratory health survey cohort Source: International Congress 2015 – New observations in respiratory epidemiology Year: 2015
Putting patients at the heart of healthcare: Respiratory allergy care in 18 European countries Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2012
Asthma control and its direct healthcare costs: findings using a derived Asthma Control TestTM score in eight Asia-Pacific areas Source: Eur Respir Rev 2006; 15: 24-29 Year: 2006